Logo-bi
Original Research
Khalil EL Khatabi ORCID, Ilham Aanouz, Marwa Alaqarbeh, Mohammed Aziz Ajana, Tahar Lakhlifi, Mohammed Bouachrine* ORCID
BioImpacts. 2022;12(2): 107-113. doi: 10.34172/bi.2021.22143
PMCID: PMC8905587     PMID: 35411302     Scopus ID: 85127183196    
Molecular docking was performed to explore the binding affinity of the 12 selected molecules in the target enzyme and then evaluated for in silico ADMET properties. The best hits were subjected to molecular dynamics simulation.
Editorial COVID-19
Jaleh Barar* ORCID
Bioimpacts. 2020;10(3): 137-138. doi: 10.34172/bi.2020.16
PMCID: PMC7416010     PMID: 32793434     Scopus ID: 85089709760    
The vast knowledge about the pathways that regulate the virus entry and molecular signaling of the pathogenesis of coronavirus are the key factor for the development of de novo nanoscaled diagnostic/therapeutic strategies.
Perspective COVID-19
Mohammad Hossein Ahmadi* ORCID
BioImpacts. 2021;11(3): 169-172. doi: 10.34172/bi.2021.12
PMCID: PMC8314034     PMID: 34336604     Scopus ID: 85109083920    
A schematic representation of the application of viral interference phenomenon in prophylaxis of COVID-19. The viral interference is a competition phenomenon by which a primary virus infecting a cell prohibits the infection of the same cell by another (secondary) virus.
Perspective
Sajad Khiali ORCID, Afra Rezagholizadeh ORCID, Taher Entezari-Maleki* ORCID
BioImpacts. 2022;12(3): 291-292. doi: 10.34172/bi.2022.23266
PMCID: PMC9124879     PMID: 35677665     Scopus ID: 85132071249    
In the present perspective piece, three possible mechanisms of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an oncogenic virus in the lung have been discussed.
Original Research
Yang Han ORCID, Zhilong Jia* ORCID, Jinlong Shi, Weidong Wang*, Kunlun He*
BioImpacts. 2022;12(2): 139-146. doi: 10.34172/bi.2021.23378
PMCID: PMC8905590     PMID: 35411293     Scopus ID: 85127131228    
The enrichment of several other pathogens, immunomodulatory probiotics (lactic acid or butyrate producers), and TMV in the COVID-19 group suggests a complex and active lung microbiota disorder.
Original Research COVID-19
Mohammad Mostafa Pourseif ORCID, Sepideh Parvizpour, Behzad Jafari, Jaber Dehghani ORCID, Behrouz Naghili, Yadollah Omidi* ORCID
BioImpacts. 2021;11(1): 65-84. doi: 10.34172/bi.2021.11
PMCID: PMC7803919     PMID: 33469510     Scopus ID: 85099197264    
Immunodominant T-cell epitopes of SARS-CoV-2 spike protein with the highest population coverage were predicted by analyzing peptide binders and consensus rank (CR) score. Multi-method B-cell epitope prediction approach was used to find B-cell immunodominant regions of spike protein. Upon the high immune-potent regions of the antigen(s), self-amplifying mRNA and peptide-based vaccines were designed.

Original Research
Ysrafil Ysrafil* ORCID, Zulfiayu Sapiun ORCID, Indwiani Astuti ORCID, Mohammad Anas Anasiru, Nangsih Sulastri Slamet ORCID, Hartati Hartati ORCID, Fadli Husain, Sukmawati Ahmad Damiti ORCID
BioImpacts. 2022;12(4): 359-370. doi: 10.34172/bi.2022.23769
PMCID: PMC9376164     PMID: 35975206     Scopus ID: 85138027836    
The two designed and constructed multiepitope vaccine have good characteristics and may have the potential to activate humoral and cellular immune responses against SARS-CoV-2. Further research is worth considering to confirm the findings of this study.
Review
Maryam Sayahinouri ORCID, Sahar Mashayekhi Firouz ORCID, Amin Ebrahimi Sadrabadi ORCID, Mina Masoudnia ORCID, Mahnaz Abdolahi ORCID, Fatemeh Jafarzadeh ORCID, Meshkat Nouripour ORCID, Sana Mirzazadeh ORCID, Nazanin Zangeneh ORCID, Arsalan Jalili* ORCID, Nasser Aghdami ORCID
Bioimpacts. 2023;13(2): 159-179. doi: 10.34172/bi.2023.23839
PMCID: PMC10182441     PMID: 37193075     Scopus ID: 85152105286    
In COVID-19 infection, the various functions of immune cells lead to defense or failure against the virus. Cell therapy is of great importance as a new treatment for COVID-19 infection. Therefore, in this review, we have dealt with the function of immune cells against the SARS-Cov-2 virus and new treatment methods for this disease with the help of different cell types


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge